What question did this study set out to answer?

The study aims to evaluate the effects of GLP-1 receptor agonists on mortality and cardiovascular risk in individuals with psoriasis and type 2 diabetes.

April 13, 2026

View Full Paper

Effect of GLP‐1RA on mortality and cardiovascular risk in adults with psoriasis and type 2 diabetes

CLClaire Lin NBNatalie BraunBrigham and Women's Hospital SCSydney CoreyHarvard University

Key Points

The study aims to evaluate the effects of GLP-1 receptor agonists on mortality and cardiovascular risk in individuals with psoriasis and type 2 diabetes.
Utilized data from TriNetX Research Network
Examined adult populations with psoriasis and type 2 diabetes
Analyzed mortality rates and cardiovascular outcomes
Findings indicate potential reductions in cardiovascular risk associated with GLP-1RA treatment
Results suggest lower mortality rates among treated individuals
Data support a favorable outcome for patients using GLP-1RA therapy

Abstract

The data that support the findings of this study are available from TriNetX Research Network. Restrictions apply to the availability of these data, which were used under licence for this study.

AI से पूछें

Bookmark

View Full Paper

AI से पूछें

Bookmark

View Full Paper

Effect of GLP‐1RA on mortality and cardiovascular risk in adults with psoriasis and type 2 diabetes

Key Points

Abstract

Cite This Study

Also Consider

Also Consider